BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24639079)

  • 1. Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes.
    Borland MG; Krishnan P; Lee C; Albrecht PP; Shan W; Bility MT; Marcus CB; Lin JM; Amin S; Gonzalez FJ; Perdew GH; Peters JM
    Carcinogenesis; 2014 Jul; 35(7):1602-12. PubMed ID: 24639079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.
    Bility MT; Devlin-Durante MK; Blazanin N; Glick AB; Ward JM; Kang BH; Kennett MJ; Gonzalez FJ; Peters JM
    Carcinogenesis; 2008 Dec; 29(12):2406-14. PubMed ID: 18799709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling.
    Zhu B; Ferry CH; Blazanin N; Bility MT; Khozoie C; Kang BH; Glick AB; Gonzalez FJ; Peters JM
    Oncogene; 2014 Nov; 33(46):5348-59. PubMed ID: 24213576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
    Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
    Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
    Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
    Kim DJ; Prabhu KS; Gonzalez FJ; Peters JM
    Carcinogenesis; 2006 May; 27(5):1105-12. PubMed ID: 16418176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
    Borland MG; Khozoie C; Albrecht PP; Zhu B; Lee C; Lahoti TS; Gonzalez FJ; Peters JM
    Cell Signal; 2011 Dec; 23(12):2039-50. PubMed ID: 21843636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress.
    Zhu B; Ferry CH; Markell LK; Blazanin N; Glick AB; Gonzalez FJ; Peters JM
    J Biol Chem; 2014 Jul; 289(29):20102-19. PubMed ID: 24898257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.
    Koga T; Yao PL; Goudarzi M; Murray IA; Balandaram G; Gonzalez FJ; Perdew GH; Fornace AJ; Peters JM
    J Biol Chem; 2016 Nov; 291(48):25255-25263. PubMed ID: 27765815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.
    Zhu B; Bai R; Kennett MJ; Kang BH; Gonzalez FJ; Peters JM
    Mol Cancer Ther; 2010 Dec; 9(12):3267-77. PubMed ID: 21159610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins.
    Di-Poï N; Desvergne B; Michalik L; Wahli W
    J Biol Chem; 2005 Nov; 280(46):38700-10. PubMed ID: 16166081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia perturbs aryl hydrocarbon receptor signaling and CYP1A1 expression induced by PCB 126 in human skin and liver-derived cell lines.
    Vorrink SU; Severson PL; Kulak MV; Futscher BW; Domann FE
    Toxicol Appl Pharmacol; 2014 Feb; 274(3):408-16. PubMed ID: 24355420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow cytotoxicity of benzo[a]pyrene is dependent on CYP1B1 but is diminished by Ah receptor-mediated induction of CYP1A1 in liver.
    Galván N; Jaskula-Sztul R; MacWilliams PS; Czuprynski CJ; Jefcoate CR
    Toxicol Appl Pharmacol; 2003 Nov; 193(1):84-96. PubMed ID: 14613719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
    Balandaram G; Kramer LR; Kang BH; Murray IA; Perdew GH; Gonzalez FJ; Peters JM
    Toxicology; 2016 Jul; 363-364():1-9. PubMed ID: 27427494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathway.
    Maayah ZH; Ghebeh H; Alhaider AA; El-Kadi AO; Soshilov AA; Denison MS; Ansari MA; Korashy HM
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):217-26. PubMed ID: 25697376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4.
    Khozoie C; Borland MG; Zhu B; Baek S; John S; Hager GL; Shah YM; Gonzalez FJ; Peters JM
    BMC Genomics; 2012 Nov; 13():665. PubMed ID: 23176727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure.
    Letavernier E; Perez J; Joye E; Bellocq A; Fouqueray B; Haymann JP; Heudes D; Wahli W; Desvergne B; Baud L
    J Am Soc Nephrol; 2005 Aug; 16(8):2395-402. PubMed ID: 15944338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism.
    Larsen MC; Angus WG; Brake PB; Eltom SE; Sukow KA; Jefcoate CR
    Cancer Res; 1998 Jun; 58(11):2366-74. PubMed ID: 9622076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of CYP1A1 and CYP1B1 in liver and lung by benzo(a)pyrene and 7,12-d imethylbenz(a)anthracene do not affect distribution of polycyclic hydrocarbons to target tissue: role of AhR and CYP1B1 in bone marrow cytotoxicity.
    Galván N; Teske DE; Zhou G; Moorthy B; MacWilliams PS; Czuprynski CJ; Jefcoate CR
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):244-57. PubMed ID: 15667830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.
    Peters JM; Kim DJ; Bility MT; Borland MG; Zhu B; Gonzalez FJ
    Mol Carcinog; 2019 Sep; 58(9):1612-1622. PubMed ID: 31062422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.